Company Presentation
PharmEasy Overview and Key Details
PharmEasy, operating under API Holdings Ltd, is a leading digital healthcare platform in India, providing online pharmacy services, medicine delivery, diagnostic test bookings, and healthcare/wellness products. It has expanded its reach via acquisitions like Medlife, Thyrocare, and Aknamed, aiming for an integrated ecosystem.
Investment Rationale: PharmEasy offers a comprehensive suite of healthcare services as a one-stop consumer solution. Strategic acquisitions have expanded service offerings and market reach. Significant reductions in marketing and employee expenses indicate a focus on cost optimization. The Indian digital healthcare market has strong growth potential.
Key Risks: Consistent net losses pose concerns about the path to profitability. A significant valuation decline may impact investor confidence and future fundraising. Regulatory challenges in the healthcare sector may affect operations. Increased competition from other digital healthcare platforms could impact market share.
Financials: PharmEasy's revenue has fluctuated, growing from ₹2335 Cr in FY21 to ₹5729 Cr in FY22, peaking at ₹6644 Cr in FY23, and then declining to ₹5664 Cr in FY24. EBITDA losses were substantial, ranging from -₹570 Cr in FY21 to -₹2345 Cr in FY22, improving to -₹1421 Cr in FY23 and further to -₹646 Cr in FY24. Net losses (PAT) followed a similar trend, from -₹642 Cr in FY21 to -₹3999 Cr in FY22, reducing to -₹5211 Cr in FY23 and -₹2533 Cr in FY24. EPS improved from -₹25.08 in FY21 to -₹3.9 in FY24.
Valuation Metrics: The last deal price was ₹8.5/share (24 Apr 2025), implying a market cap of ₹5463 Cr. Book value stood at ₹4.03, resulting in a P/B Ratio of 2.11. The debt-to-equity ratio was 1.58, and the return on equity was -97.89%. It is important to note the valuation decline from a peak of $5.6 billion to approximately $456 million as of December 2024.
Shareholding Pattern: The majority of shares (57.29%) are held by 'Others.' Naspers Ventures B.V. holds 13.03%, MacRitchie Investments Pte. Ltd. holds 11.74%, TPG Growth V SF Markets Pte. Ltd. holds 7.20%, Evermed Holdings Pte. Ltd. holds 6.35%, and Prasid Uno Family Trust, through its trustee Surbhi Singh, holds 4.39%.
IPO Timeline & Exit Options: The IPO, initially planned for 2021, has been postponed due to financial and market conditions. Investors may consider secondary market transactions or await future public listing opportunities.
UnlistedZone View: PharmEasy's integrated approach to digital healthcare presents a compelling value proposition. Financial performance and valuation trends necessitate cautious optimism. Potential investors should closely monitor the company's path to profitability and market positioning. The rating is hold with a long-term perspective. Target valuation post-IPO is subject to market conditions and company performance.
Access essential information and documents to make informed investment decisions
Stay updated with upcoming events, conferences, and announcements
Access quarterly and half-yearly financial statements and reports
Download comprehensive annual reports and financial summaries
Access investor presentations, corporate briefings, and slideshows
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.
Unlisted shares are stocks of companies that are not listed on any stock exchange, meaning they are not publicly traded. These shares are typically available for trade in the private market through brokers, and can offer unique investment opportunities.
You can buy unlisted shares through a broker or platform that specializes in unlisted share transactions. We provide a secure and easy way to purchase unlisted shares from top companies, ensuring a smooth transaction process.
The share prices of unlisted companies can fluctuate based on various factors like market demand, company performance, and private transactions. You can check the latest share prices for unlisted companies on our website for real-time updates.
Unlisted shares can offer higher growth potential, as they are typically not subject to the same market volatility as listed shares. However, they come with higher risk due to limited liquidity and availability of information. It's important to research thoroughly and consult experts before investing.
To sell unlisted shares, you can connect with a broker or platform that facilitates the sale of private stocks. We help investors buy and sell unlisted shares with ease, ensuring that your transaction is handled professionally and securely.
Yes, unlisted shares can eventually be listed on a stock exchange through an Initial Public Offering (IPO). This process allows the company to offer its shares publicly and be traded on major exchanges, potentially increasing liquidity and visibility.
Gains from unlisted shares are subject to capital gains tax in India. Short-term capital gains (if held for less than 24 months) are taxed at your applicable income tax rate, while long-term capital gains (if held for more than 24 months) are taxed at 20% with indexation benefits. Always consult a tax advisor for precise tax implications.
The value of unlisted shares is typically determined by private transactions, financial reports, and market demand. We provide the latest updates on share prices of unlisted companies, giving you the most accurate valuation available.
The minimum investment for unlisted shares can vary depending on the company and broker. Generally, the minimum investment is higher than for listed stocks, but we provide detailed information to help you make the best investment decisions.
Yes, unlisted shares may pay dividends if the company has declared them. However, since these companies may be in their growth stage, dividend payments are not always guaranteed. It's important to check the company's financial health before investing.
It's important to conduct thorough research on the company's financials, management, market potential, and overall business model. You can also seek professional advice from experts to help you choose unlisted shares with strong growth prospects.
Gains from unlisted shares are subject to capital gains tax in India. Short-term capital gains (if held for less than 24 months) are taxed at your applicable income tax rate, while long-term capital gains (if held for more than 24 months) are taxed at 20% with indexation benefits. Always consult a tax advisor for precise tax implications.
